Global Terbinafine Hydrochloride Drug Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ918412
Publisher: Date of Publish:
No. of Pages: 150 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Executive Summary According to GRD Survey data, the global Terbinafine Hydrochloride Drug market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027. This report studies the Terbinafine Hydrochloride Drug market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Terbinafine Hydrochloride Drug in these regions, from 2016 to 2027, covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Italy, Spain and Russia, etc.) Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.) Market Snapshot, By Product Type Topical Oral Market Snapshot, By Application Fingernail Infection Toenail Infection Others Market Snapshot, By Region: North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australia Central & South America Brazil Argentina Colombia Middle East & Africa Iran South Africa Israel Turkey Saudi Arabia Main Market Players Analyzed in this report, including: Xiuzheng Pharmaceutical TEVA TARO Orchid Healthcare Novartis Jilin Wantong Group InvaGen Pharmaceuticals Hubei Hengan Fulin Pharm Harris Pharmaceutical GSK Glenmark Dr. Reddy's Laboratories Cussess CIPLA LTD Breckenridge Pharmaceutical APOTEX The study objectives of this report are: To study and analyze the global Terbinafine Hydrochloride Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027. To understand industry structure of Terbinafine Hydrochloride Drug market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To identify the key global Terbinafine Hydrochloride Drug manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Terbinafine Hydrochloride Drug market with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Terbinafine Hydrochloride Drug submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Terbinafine Hydrochloride Drug are as follows: History Year: 2016-2020 Base Year: 2020 Estimated Year: 2021 Forecast Year 2021 to 2027 This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Considered in the study: Raw material vendors Distributors/traders/wholesalers/suppliers Regulatory authorities, including government agencies and NGO Commercial research & development (R&D) institutions Importers and exporters Government organizations, research organizations, and consulting firms Trade/Industrial associations End-use industries
Table of Contents 1 Market Definition & Scope 1.1 Definition & Scope 1.2 Terbinafine Hydrochloride Drug Product Specifications 1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity) 1.4 Global Terbinafine Hydrochloride Drug Market Performance and Outlook 2 Market Development Performance under COVID-19 2.1 Influencing Factors of Industry Development in the Next Five Years 2.1.1 Drivers 2.1.2 Restraints 2.1.3 Opportunities 2.2 Porter’s Five Forces Analysis 2.3 Comparison of Alternatives and Terbinafine Hydrochloride Drug 3 Supply Chain and Manufacturing Cost Analysis 3.1 Supply Chain Analysis 3.2 Raw Materials and Key Suppliers Analysis 3.2.1 Raw Materials Introduction 3.2.1 Raw Materials Key Suppliers List 3.3 Terbinafine Hydrochloride Drug Sales Channel and Distributors Analysis 3.3.1 Terbinafine Hydrochloride Drug Sales Channel 3.3.2 Terbinafine Hydrochloride Drug Distributors 3.4 Key Buying Industries/Consumers 3.4.1 Major Buyers in Fingernail Infection 3.4.2 Major Buyers in Toenail Infection 3.5 Terbinafine Hydrochloride Drug Manufacturing Cost Structure Analysis 4 Market Segment: by Type 4.1 Terbinafine Hydrochloride Drug Type Introduction 4.1.1 Topical 4.1.2 Oral 4.2 Global Terbinafine Hydrochloride Drug Sales by Type 2016-2021 4.3 Global Terbinafine Hydrochloride Drug Revenue by Type 2016-2021 4.4 Global Terbinafine Hydrochloride Drug Price by Type 2016-2021 5 Market Segment: by Application 5.1 Terbinafine Hydrochloride Drug Type Introduction 5.1.1 Fingernail Infection 5.1.2 Toenail Infection 5.1.3 Others 5.2 Global Terbinafine Hydrochloride Drug Sales by Application 2016-2021 5.3 Global Terbinafine Hydrochloride Drug Revenue by Application 2016-2021 5.4 Global Terbinafine Hydrochloride Drug Price by Application 2016-2021 6 Marke Segment: by Region 6.1 Global Terbinafine Hydrochloride Drug Market by Region 6.1.1 Global Terbinafine Hydrochloride Drug Sales by Regions 6.1.2 Global Terbinafine Hydrochloride Drug Revenue by Regions 6.2 North America Terbinafine Hydrochloride Drug Market 2016-2021 6.3 Europe Terbinafine Hydrochloride Drug Market 2016-2021 6.4 Asia Pacific Terbinafine Hydrochloride Drug Market 2016-2021 6.5 South America Terbinafine Hydrochloride Drug Market 2016-2021 6.6 Middle East and Africa Terbinafine Hydrochloride Drug Market 2016-2021 7 North America 7.1 North America Terbinafine Hydrochloride Drug Market by Country 2016-2021 7.1.1 North America Terbinafine Hydrochloride Drug Sales by Country 7.1.2 North America Terbinafine Hydrochloride Drug Revenue by Country 7.2 United States 7.3 Canada 7.4 Mexico 8 Europe 8.1 Europe Terbinafine Hydrochloride Drug Market by Country 2016-2021 8.1.1 Europe Terbinafine Hydrochloride Drug Sales by Country 8.1.2 Europe Terbinafine Hydrochloride Drug Revenue by Country 8.2 Germany 8.3 France 8.4 UK 8.5 Italy 8.6 Russia 8.7 Spain 9 Asia Pacific 9.1 Asia Pacific Terbinafine Hydrochloride Drug Market by Country 2016-2021 9.1.1 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country 9.1.2 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Country 9.2 China 9.3 Japan 9.4 Korea 9.5 Southeast Asia 9.6 India 9.7 Australia 10 South America 10.1 South America Terbinafine Hydrochloride Drug Market by Country 2016-2021 10.1.1 South America Terbinafine Hydrochloride Drug Sales by Country 10.1.2 South America Terbinafine Hydrochloride Drug Revenue by Country 10.2 Brazil 10.3 Argentina 10.4 Colombia 11 Middle East and Africa 11.1 Middle East and Africa Terbinafine Hydrochloride Drug Market by Country 2016-2021 11.1.1 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country 11.1.2 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country 11.2 Turkey 11.3 Saudi Arabia 11.4 South Africa 12 Key Participants Company Information 12.1 Xiuzheng Pharmaceutical 12.1.1 Xiuzheng Pharmaceutical Company Information 12.1.2 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.1.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.1.4 Xiuzheng Pharmaceutical Key Development 12.2 TEVA 12.2.1 TEVA Company Information 12.2.2 TEVA Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.2.3 TEVA Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.2.4 TEVA Key Development 12.3 TARO 12.3.1 TARO Company Information 12.3.2 TARO Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.3.3 TARO Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.3.4 TARO Key Development 12.4 Orchid Healthcare 12.4.1 Orchid Healthcare Company Information 12.4.2 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.4.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.4.4 Orchid Healthcare Key Development 12.5 Novartis 12.5.1 Novartis Company Information 12.5.2 Novartis Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.5.3 Novartis Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.5.4 Novartis Key Development 12.6 Jilin Wantong Group 12.6.1 Jilin Wantong Group Company Information 12.6.2 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.6.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.6.4 Jilin Wantong Group Key Development 12.7 InvaGen Pharmaceuticals 12.7.1 InvaGen Pharmaceuticals Company Information 12.7.2 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.7.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.7.4 Jilin Wantong Group Key Development 12.9 Harris Pharmaceutical 12.9.1 Harris Pharmaceutical Company Information 12.9.2 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.9.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.9.4 Harris Pharmaceutical Key Development 12.8 Hubei Hengan Fulin Pharm 12.8.1 Hubei Hengan Fulin Pharm Company Information 12.8.2 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.8.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.8.4 Hubei Hengan Fulin Pharm Key Development 12.11 Glenmark 12.11.1 Glenmark Company Information 12.11.2 Glenmark Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.11.3 Glenmark Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.11.4 Glenmark Key Development 12.12 Dr. Reddy's Laboratories 12.12.1 Dr. Reddy's Laboratories Company Information 12.12.2 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.12.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.12.4 Dr. Reddy's Laboratories Key Development 12.13 Cussess 12.13.1 Cussess Company Information 12.13.2 Cussess Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.13.3 Cussess Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.13.4 Cussess Key Development 12.14 CIPLA LTD 12.14.1 CIPLA LTD Company Information 12.14.2 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.14.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.14.4 CIPLA LTD Key Development 12.15 Breckenridge Pharmaceutical 12.15.1 Breckenridge Pharmaceutical Company Information 12.15.2 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio, Specification and Application 12.15.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Price, Revenue and Gross Margin (2019-2021) 12.15.4 Breckenridge Pharmaceutical Key Development 13 Global Terbinafine Hydrochloride Drug Market Forecast by Region by Type and by Application 13.1 Global Terbinafine Hydrochloride Drug Sales, Revenue Forecast 2022-2027 13.2 Global Terbinafine Hydrochloride Drug Forecast by Regions 13.2.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Region 2022-2027 13.2.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Region 2022-2027 13.3 Global Terbinafine Hydrochloride Drug Forecast by Type 13.3.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Type 2022-2027 13.3.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Type 2022-2027 13.3.3 Global Terbinafine Hydrochloride Drug Price Forecast by Type 2022-2027 13.4 Global Terbinafine Hydrochloride Drug Forecast by Application 13.4.1 Global Terbinafine Hydrochloride Drug Sales Forecast by Application 2022-2027 13.4.2 Global Terbinafine Hydrochloride Drug Revenue Forecast by Application 2022-2027 13.4.3 Global Terbinafine Hydrochloride Drug Price Forecast by Application 2022-2027 14 Analyst Views and Conclusions 15 Methodology and Data Source 15.1 Methodology 15.2 Research Data Source 15.2.1 Secondary Data 15.2.2 Primary Data 15.2.3 Market Size Estimation 15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com